Lovastatin Inhibits TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts
Meyer-ter-Vehn et al.
IOVS 2008;49:3955-3960.
ABSTRACT
| FULL TEXT
Assessing Multiple Medication Use With Probabilities of Benefits and Harms
Murphy et al.
J Aging Health 2008;20:694-709.
ABSTRACT
Interaction between statins and clopidogrel: is there anything clinically relevant?
Bhindi et al.
QJM 2008;0:hcn089v1-hcn089.
ABSTRACT
| FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT
| FULL TEXT
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study
Wenger et al.
Heart 2008;94:434-439.
ABSTRACT
| FULL TEXT
Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment
Krauss et al.
Circulation 2008;117:1537-1544.
ABSTRACT
| FULL TEXT
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial.
Miller et al.
J Am Coll Cardiol 2008;51:724-730.
ABSTRACT
| FULL TEXT
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Superko and King
Circulation 2008;117:560-568.
FULL TEXT
Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
Afilalo et al.
J Am Coll Cardiol 2008;51:37-45.
ABSTRACT
| FULL TEXT
EP2306 [2-(4-Biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], A Novel Squalene Synthase Inhibitor, Reduces Atherosclerosis in the Cholesterol-Fed Rabbit
Tavridou et al.
J. Pharmacol. Exp. Ther. 2007;323:794-804.
ABSTRACT
| FULL TEXT
Atorvastatin Treatment and Vaccination Efficacy
Packard et al.
J Clin Pharmacol 2007;47:1022-1027.
FULL TEXT
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Nogueira and Weir
CJASN 2007;2:766-785.
ABSTRACT
| FULL TEXT
Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation
Brusselmans et al.
J. Biol. Chem. 2007;282:18777-18785.
ABSTRACT
| FULL TEXT
Risk assessment in diabetes management: how do general practitioners estimate risks due to diabetes?
Haussler et al.
Qual Saf Health Care 2007;16:208-212.
ABSTRACT
| FULL TEXT
Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
Kastelein et al.
NEJM 2007;356:1620-1630.
ABSTRACT
| FULL TEXT
A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis
Patel et al.
Eur Heart J 2007;28:664-672.
ABSTRACT
| FULL TEXT
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley et al.
NEJM 2007;356:775-789.
ABSTRACT
| FULL TEXT
Effects of Past and Recent Blood Pressure and Cholesterol Level on Coronary Heart Disease and Stroke Mortality, Accounting for Measurement Error
Boshuizen et al.
Am J Epidemiol 2007;165:398-409.
ABSTRACT
| FULL TEXT
Statin Therapy and the Elderly: SAGE Advice?
Gotto
Circulation 2007;115:681-683.
FULL TEXT
Sex differences in the effectiveness of statins after myocardial infarction
Karp et al.
CMAJ 2007;176:333-338.
ABSTRACT
| FULL TEXT
Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT
| FULL TEXT
Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study
Penning-van Beest et al.
Eur Heart J 2007;28:154-159.
ABSTRACT
| FULL TEXT
Primary Prevention of Cardiovascular Diseases With Statin Therapy: A Meta-analysis of Randomized Controlled Trials
Thavendiranathan et al.
Arch Intern Med 2006;166:2307-2313.
ABSTRACT
| FULL TEXT
Cholesteryl Ester Transfer Protein Inhibition: The Next Frontier in Combating Coronary Artery Disease?
Milani and Lavie
J Am Coll Cardiol 2006;48:1791-1792.
FULL TEXT
Statin therapy and risks for death and hospitalization in chronic heart failure.
Go et al.
JAMA 2006;296:2105-2111.
ABSTRACT
| FULL TEXT
Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?
van Leuven et al.
Lupus 2006;15:11-17.
ABSTRACT
Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.
Franco et al.
J. Epidemiol. Community Health 2006;60:839-845.
ABSTRACT
| FULL TEXT
The gap between theory and practice: what do the trials tell us?
Pedersen
Eur Heart J Suppl 2006;8:F10-F16.
ABSTRACT
| FULL TEXT
Epidemiology of low HDL-cholesterol: results of studies and surveys
Bruckert
Eur Heart J Suppl 2006;8:F17-F22.
ABSTRACT
| FULL TEXT
Niaspan(R) in the management of dyslipidaemia: the evidence
Brown
Eur Heart J Suppl 2006;8:F60-F67.
ABSTRACT
| FULL TEXT
Simvastatin-Induced Decline in Cognition
Padala et al.
The Annals of Pharmacotherapy 2006;40:1880-1883.
ABSTRACT
| FULL TEXT
Potential therapeutic role for statins in respiratory disease.
Hothersall et al.
Thorax 2006;61:729-734.
ABSTRACT
| FULL TEXT
A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT
| FULL TEXT
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
Manuel et al.
BMJ 2006;332:1419.
ABSTRACT
| FULL TEXT
Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.
Paul-Labrador et al.
Arch Intern Med 2006;166:1218-1224.
ABSTRACT
| FULL TEXT
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina
Daly et al.
Eur Heart J 2006;27:1298-1304.
ABSTRACT
| FULL TEXT
Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk
El Fakiri et al.
Heart 2006;92:741-745.
ABSTRACT
| FULL TEXT
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
Stramba-Badiale et al.
Eur Heart J 2006;27:994-1005.
ABSTRACT
| FULL TEXT
Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.
Pignone et al.
ANN INTERN MED 2006;144:326-336.
ABSTRACT
| FULL TEXT
The polypill: at what price would it become cost effective?
Franco et al.
J. Epidemiol. Community Health 2006;60:213-217.
ABSTRACT
| FULL TEXT
Apparent and Internal Validity of a Monte Carlo-Markov Model for Cardiovascular Disease in a Cohort Follow-up Study.
Nijhuis et al.
Med Decis Making 2006;26:134-144.
ABSTRACT
Statin Treatment and Diabetes Affect Myeloperoxidase Activity in Maintenance Hemodialysis Patients
Stenvinkel et al.
CJASN 2006;1:281-287.
ABSTRACT
| FULL TEXT
Inflammation and cardiovascular disease mechanisms
Libby
Am. J. Clin. Nutr. 2006;83:456S-460S.
ABSTRACT
| FULL TEXT
Mycophenolate mofetil (MMF): Firing at the atherosclerotic plaque from different angles?
van Leuven et al.
Cardiovasc Res 2006;69:341-347.
ABSTRACT
| FULL TEXT
Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins
Urso et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:2560-2566.
ABSTRACT
| FULL TEXT
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia
Despres et al.
NEJM 2005;353:2121-2134.
ABSTRACT
| FULL TEXT
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?: A Meta-Regression Analysis
Robinson et al.
J Am Coll Cardiol 2005;46:1855-1862.
ABSTRACT
| FULL TEXT
Cost effectiveness of statins in coronary heart disease
Franco et al.
J. Epidemiol. Community Health 2005;59:927-933.
ABSTRACT
| FULL TEXT
Perspectives on Dyslipidemia and Coronary Heart Disease in Women
Bittner
J Am Coll Cardiol 2005;46:1628-1635.
ABSTRACT
| FULL TEXT
Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002
Carroll et al.
JAMA 2005;294:1773-1781.
ABSTRACT
| FULL TEXT
Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review
Iestra et al.
Circulation 2005;112:924-934.
ABSTRACT
| FULL TEXT
Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis
Hayashida et al.
Circulation 2005;112:812-818.
ABSTRACT
| FULL TEXT
The realities of dyslipidaemia: what do the studies tell us?
Kastelein
Eur Heart J Suppl 2005;7:F27-F33.
ABSTRACT
| FULL TEXT
Commentary
Levy and Pearson
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:597-598.
FULL TEXT
Potential Adverse Effects of Statins on Muscle
Tomlinson and Mangione
ptjournal 2005;85:459-465.
FULL TEXT
The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed
Manuel et al.
CMAJ 2005;172:1027-1031.
FULL TEXT
The analysis by Manuel and colleagues creates controversy with headlines, not data
Genest et al.
CMAJ 2005;172:1033-1034.
FULL TEXT
Effect of Intensive Lipid Lowering, With or Without Antioxidant Vitamins, Compared With Moderate Lipid Lowering on Myocardial Ischemia in Patients With Stable Coronary Artery Disease: The Vascular Basis for the Treatment of Myocardial Ischemia Study
Stone et al.
Circulation 2005;111:1747-1755.
ABSTRACT
| FULL TEXT
Simvastatin over the counter
DTB 2005;43:25-28.
ABSTRACT
| FULL TEXT
Statins and Blood Coagulation
Undas et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:287-294.
ABSTRACT
| FULL TEXT
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: A meta-analysis of randomized controlled trials
Birjmohun et al.
J Am Coll Cardiol 2005;45:185-197.
ABSTRACT
| FULL TEXT
Raising HDL-C and lowering triglycerides: benefits beyond LDL-C modification
Shepherd
British Journal of Diabetes & Vascular Disease 2005;5:S12-S16.
ABSTRACT
Modern intervention strategies for managing dyslipidaemia: the case for combination therapy
Drexel
British Journal of Diabetes & Vascular Disease 2005;5:S17-S23.
ABSTRACT
Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
Meagher
J Am Board Fam Med 2004;17:424-437.
ABSTRACT
| FULL TEXT
CRP and Risk of Coronary Heart Disease: Can Exercise Training Cool Down the Flames?
Despres
Arterioscler. Thromb. Vasc. Bio. 2004;24:1743-1745.
FULL TEXT
Long term persistence with statin treatment in daily medical practice
Mantel-Teeuwisse et al.
Heart 2004;90:1065-1066.
FULL TEXT
Impact of Angiotensin-Converting Enzyme Inhibitors and Statins on Survival in Idiopathic Pulmonary Fibrosis
Nadrous et al.
Chest 2004;126:438-446.
ABSTRACT
| FULL TEXT
Management of dyslipidaemia
Thompson
Heart 2004;90:949-955.
FULL TEXT
Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China
He et al.
Circulation 2004;110:405-411.
ABSTRACT
| FULL TEXT
Foreword
LaRosa and Pedersen
Eur Heart J Suppl 2004;6:C1-C4.
FULL TEXT
Observational Studies of Treatment Effectiveness: Some Cautions
Laupacis and Mamdani
ANN INTERN MED 2004;140:923-924.
FULL TEXT
Commentary: Observation versus intervention--what's different?
Barrett-Connor
Int J Epidemiol 2004;33:457-459.
FULL TEXT
Drug Treatment of Hyperlipidemia in Women
Walsh and Pignone
JAMA 2004;291:2243-2252.
ABSTRACT
| FULL TEXT
Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox
Ko et al.
JAMA 2004;291:1864-1870.
ABSTRACT
| FULL TEXT
Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction
Dalal et al.
BMJ 2004;328:693-697.
FULL TEXT
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease
Emberson et al.
Eur Heart J 2004;25:484-491.
ABSTRACT
| FULL TEXT
Hypothesis: Atorvastatin Has Pleiotropic Effects that Translate into Early Clinical Benefits on Cardiovascular Disease
Novela and Hennekens
J CARDIOVASC PHARMACOL THER 2004;9:61-63.
ABSTRACT
Patient Safety Is Not Enough: Targeting Quality Improvements To Optimize the Health of the Population
Woolf
ANN INTERN MED 2004;140:33-36.
ABSTRACT
| FULL TEXT
Coronary heart disease prevention: insights from modelling incremental cost effectiveness
Marshall
BMJ 2003;327:1264.
ABSTRACT
| FULL TEXT
The use of cholesterol-lowering medications after coronary revascularization
Brophy et al.
CMAJ 2003;169:1153-1157.
ABSTRACT
| FULL TEXT
In-Hospital Initiation of Lipid-Lowering Therapy After Coronary Intervention as a Predictor of Long-term Utilization: A Propensity Analysis
Aronow et al.
Arch Intern Med 2003;163:2576-2582.
ABSTRACT
| FULL TEXT
Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study
LaCroix et al.
ANN INTERN MED 2003;139:97-104.
ABSTRACT
| FULL TEXT
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
Law et al.
BMJ 2003;326:1423.
ABSTRACT
| FULL TEXT
Sympathetic Nerve Sprouting, Electrical Remodeling, and Increased Vulnerability to Ventricular Fibrillation in Hypercholesterolemic Rabbits
Liu et al.
Circ. Res. 2003;92:1145-1152.
ABSTRACT
| FULL TEXT
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
DeWilde et al.
Heart 2003;89:417-421.
ABSTRACT
| FULL TEXT
Risk for Myopathy With Statin Therapy in High-Risk Patients
Ballantyne et al.
Arch Intern Med 2003;163:553-564.
ABSTRACT
| FULL TEXT
Controlled trial of effect of documented cardiovascular risk scores on prescribing
Hall et al.
BMJ 2003;326:251-252.
FULL TEXT
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Lalouschek et al.
Stroke 2003;34:105-110.
ABSTRACT
| FULL TEXT
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
The ALLHAT Officers and Coordinators for the ALLHA
JAMA 2002;288:2998-3007.
ABSTRACT
| FULL TEXT
The ALLHAT Lipid Lowering Trial--Less Is Less
Pasternak
JAMA 2002;288:3042-3044.
FULL TEXT
Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands
Marang-van de Mheen et al.
Eur Heart J 2002;23:1922-1930.
ABSTRACT
